Trust Stamp Inc (NASDAQ:IDAI, EURONEXT:AIID) earlier this week discussed its upcoming biometric TSI wallet, which combines digital asset storage and identity verification capabilities, in an interview with Proactive.
Trust Stamp executive vice president John Bridge explained that the wallet will support token-enabled KYC features, allowing users to manage their own identity verification credentials.
Abacus Global Management (NASDAQ:ABL) raised its full-year profit outlook and announced its first-ever dividend after posting a sharp rise in quarterly revenue and earnings, driven by demand for its longevity-based assets.
The alternative asset manager said third-quarter revenue surged 124% to $63 million from a year earlier, supported by growth in its Life Solutions and Longevity Funds segments and higher asset management fees from recent acquisitions.
Despite a host of economic headwinds—from a protracted government shutdown to historically high tariffs and rising consumer prices—stocks may still have reason to cheer as the year draws to a close. In his latest analysis, Frank Holmes, CEO of U.S. Global Investors (NASDAQ:GROW), examines why historical market patterns, including the so-called “Halloween effect,” suggest that investors could be in for a seasonal rally, even amid inflationary pressures and supply-chain shocks.
Want to hear something really scary?
Alvopetro Energy Ltd (TSX-V:ALV, OTC:ALVOF) delivered a strong third-quarter performance fueled by output from its Murucututu field in Brazil, prompting analysts to highlight the company’s dual-track growth strategy across South America and Canada.
The Calgary-based oil and gas company reported average third-quarter production of 2,343 barrels of oil equivalent per day (boe/d), up 11% year-over-year, generating $14.2 million in revenue.
Bit Digital Inc (NASDAQ:BTBT) said on Friday it held about 153,547 ether (ETH) valued at roughly $590.5 million at the end of October.
The New York-based digital asset company said it acquired 31,057 ETH during the month at an average total acquisition price of $3,045.14 per token. Ether closed October at $3,845.79.
Highland Critical Minerals Corp (CSE:HLND) announced that it has entered into a binding letter of intent (LOI) to acquire a 100% interest in certain mining claims located in Canada's Nunavut territory.
The mineral exploration and development company said the mining claims consist of about 3,138.874 hectares of mineral exploration property located in the Yathkyed Lake Greenstone Belt in Nunavut’s Kivalliq Region.
First Phosphate Corp. (CSE:PHOS, OTCQX:FRSPF) has announced a non-brokered private placement to a strategic investor for minimum gross proceeds of $2 million.
The offering will include a combination of flow-through shares, priced at $0.90 per share, and hard dollar units, also priced at $0.90 per unit.
Analysts at Zacks have issued a new report on clinical stage biotech NanoViricides (NYSE-A:NNVC), saying that its lead drug candiate NV-387 shows broad-spectrum antiviral potential ahead of a Phase 2 clinical trial for the treatment of Mpox.
The trial will take place in the Democratic Republic of Congo, where the recent Mpox outbreak has been concentrated and will evaluate the safety, tolerability, and efficacy of NV-387 in combination with standard of care.
BioHarvest Sciences Inc. (NASDAQ:BHST) announced that it has priced its underwritten public offering of 2,485,000 company shares at $7 per share, for expected gross proceeds of about $17.4 million.
The company said it expects to use the net proceeds from the offering for research and development, manufacturing, marketing, advancing the CDMO business unit, debt reduction or debt refinancing, capital expenditures, and general corporate purposes, including funding working capital.
Argo Blockchain PLC (LSE:ARB, OTCQX:ARBKF, NASDAQ:ARBK) shares fell 9% at 2p on Friday and are down 58% over the past month after the company said it had secured court approval to move ahead with its restructuring process.
The High Court in London has given the cryptocurrency miner permission to convene three meetings on 2 December, for shareholders, noteholders, and its secured lender, Growler Mining Tuscaloosa, to vote on its proposed restructuring plan under Part 26A of the Companies Act.
Shares in Savannah Resources PLC (AIM:SAV, ETR:SAV, OTC:SAVNF) climbed 5% to 3.68p after the company completed an oversubscribed £9.2 million placing and subscription to fund expansion at its Barroso Lithium Project in northern Portugal.
The fundraising, which was scaled back due to strong investor demand, saw new shares issued at 3.7p each, with additional funds expected from a separate retail offer open until 11 November.
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) said on Friday that new data from its mid-stage cancer trial suggest its experimental therapy could outperform existing treatments for advanced melanoma, the most serious form of skin cancer.
The Oxford-based biotechnology company presented the results at a major immunotherapy conference in the United States, saying its iSCIB1+ treatment, a DNA-based immunotherapy designed to boost the body’s immune response against tumours, showed encouraging efficacy and safety.
Kairos Minerals Ltd (ASX:KAI, OTCQB:KAIFF) earlier this week provided an update on its exploration activities at the Mt York Gold Project in Western Australia.
The company said it had commenced a 10,000-metre RC and diamond drilling program targeting a 1.5-kilometre extension to its existing gold resource. The current resource stands at 1.40 million ounces across three kilometres of strike. Kairos Minerals confirmed it already has two rigs onsite and expects up to four to be active by the end of the campaign.
Resolution Minerals Ltd (ASX:RML, OTC:RLMLF) earlier this week reported a third significant drill intercept at the Golden Gate target, part of its Horse Heaven gold project in the United States.
The company said the new hole returned 253 metres at 1.5 grams per tonne gold. Within that, it highlighted a higher-grade zone of 120 metres at 2.3 grams per tonne. The company stated that this result supports its geological model, with low-grade oxidised material near the surface transitioning into higher-grade sulphide mineralisation at depth.
Imugene Ltd (ASX:IMU, OTC:IUGNF) earlier this week provided an update on its cell therapy candidate azer-cel, highlighting strong response rates and upcoming regulatory and scientific milestones.
The company said azer-cel achieved an 81% response rate in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who had previously failed autologous CAR-T therapy. It added that a newly opened cohort of CAR-T naïve patients, a group with no approved CAR-T options, showed an 83% response rate.
Terrain Minerals Ltd (ASX:TMX, OTC:TMXAF) earlier this week discussed recent rare earths intercepts at its Lort River project in Western Australia.
The company said results were returned from a shallow clay zone within a 66.00 square kilometre regolith basin in the Fraser Range. It believes the rare earths may be hosted in a new geological setting sitting over an intrusive unit. It added that fieldwork continues on a near-weekly basis and that further drilling is being planned.